RxDoctor Payments Data

Barbara Harper

Women's Health · Hermitage, PANPI 1750452975

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $598 and has fallen 68.1% since, to $191 in 2024.

$1,203in general payments, 2019–2025

Across 62 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$186
  • Evofem Biosciences, Inc.$172
  • Agile Therapeutics, Inc.$115
  • Astellas Pharma US Inc$103
  • Bayer$88
  • Organon$69
  • plus $470 from 15 others

What the payments were for

  • Food & beverage$1,203100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,203 in reported general payments places this provider in the 80th percentile of 250 women's health providers in Pennsylvania.

See all women's health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$7,050
Medicare patients
121
Services billed
153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol76$5,632
ValacyclovirValacyclovir Hcl24$474
Raloxifene Hcl21$462
Clobetasol Propionate13$257
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$119
Fluconazole17$57
Triamcinolone Acetonide23$37
Paroxetine Hcl12$1

Paid to pharmacies, not to this prescriber.

Other women's health in Hermitage

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →